ASC-US 환자에서 HPV DNA Microchip Test의 유용성
The Usefulness of the HPV DNA Microchip Test for Women with ASC-US
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : This study was performed to ascertain the usefulness of the human papillomavirus (HPV) DNA microchip test for the screening and management of women with atypical squamous cells of undetermined significance (ASC-US). Methods : The subject group consisted of 534 patients, and all of whom were diagnosed as ASC-US according to a Papanicolaou smear, and they all underwent concomitant HPV DNA microchip test. Results : The occurrence rates of overall squamous lesions and high risk lesion (cervical intraepithelial neoplasia grade 2 and grade 3, and invasive carcinoma) of the HPV-positive ASC-US patients were significantly higher than those of the HPV-negative ASC-US patients. High risk lesion was detected more frequently among the older patients and the patients with HPV 56, 33 or 70. On the follow-up HPV DNA microchip test, only 1 of 11 (9.1%) HPV type-switched women developed squamous lesion compared with 8 of 13 (61.6%) HPV type-persistent women who developed squamous lesion. Conclusions : The HPV DNA microchip test is useful for the management of ASC-US patients. HPV-positive ASC-US patients should undergo a HPV DNA microchip test periodically. If the same genotype of HPV is persistent on the follow-up test, more increased surveillance is needed.
Abstract
Background : This study was performed to ascertain the usefulness of the human papillomavirus (HPV) DNA microchip test for the screening and management of women with atypical squamous cells of undetermined significance (ASC-US). Methods : The subject group consisted of 534 patients, and all of whom were diagnosed as ASC-US according to a Papanicolaou smear, and they all underwent concomitant HPV DNA microchip test. Results : The occurrence rates of overall squamous lesions and high risk lesion (cervical intraepithelial neoplasia grade 2 and grade 3, and invasive carcinoma) of the HPV-positive ASC-US patients were significantly higher than those of the HPV-negative ASC-US patients. High risk lesion was detected more frequently among the older patients and the patients with HPV 56, 33 or 70. On the follow-up HPV DNA microchip test, only 1 of 11 (9.1%) HPV type-switched women developed squamous lesion compared with 8 of 13 (61.6%) HPV type-persistent women who developed squamous lesion. Conclusions : The HPV DNA microchip test is useful for the management of ASC-US patients. HPV-positive ASC-US patients should undergo a HPV DNA microchip test periodically. If the same genotype of HPV is persistent on the follow-up test, more increased surveillance is needed.
참고문헌 (13)
- Wright TC Jr, "2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests", Am J Obstet Gynecol, 197, pp.346~355 (2007)
- Kulasingam SL, "Evaluation of human papillomavirus testing in primary screening for cervical abnormalities:comparison of sensitivity, specificity, and frequency of referral", Jama, 288, pp.1749~1757 (2002)
- Wright JD, "Human papillomavirus triage for young women with atypical squamous cells of undetermined significance", Obstet Gynecol, 107, pp.822~829 (2006)
- Tong SY, "Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix", Int J Gynecol Cancer, 17, pp.1307~1313 (2007)
- Kulmala SM, "Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools", J Clin Microbiol, 42, pp.2470~2475 (2004)
- Cox JT, "Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management", Obstet Gynecol Surv, 61, pp.S15~S25 (2006)
- Ronco G, "HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology", Eur J Cancer, 43, pp.476~480 (2007)
- Sarode VR, "Reflex human papillomavirus DNA testing on residual liquid-based (TPPT) cervical samples: focus on age-stratified clinical performance", Cancer, 99, pp.149~155 (2003)
- Eltoum IA, "Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women", Cancer, 105, pp.194~198 (2005)
- Feng J, "Significance of high-risk human papillomavirus DNA-positive atypical squamous cells of undetermined significance pap smears in perimenopausal and postmenopausal women", Acta Cytol, 52, pp.434~438 (2008)
- Lee HS, "Human papillomavirus genotyping using HPV DNA chip analysis in Korean women", Int J Gynecol Cancer, 17, pp.497~501 (2007)
- Munoz N, "Epidemiologic classification of human papillomavirus types associated with cervical cancer", N Engl J Med, 348, pp.518~527 (2003)
- Wallin KL, "Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer", N Engl J Med, 341, pp.1633~1638 (1999)